# Checklist: consent and redisclosure of substance use disorder records under the 2024 Part 2 rule

Thirteen steps for Part 2 programs and the providers, plans and other lawful holders that receive their records, on the consent form, the notice that travels with each disclosure, and what recipients may do next, under rules with a compliance date of February 16, 2026.

Checklist · Healthcare · Regulation & Compliance. Published November 14, 2026. Last reviewed November 14, 2026.

## What changed and when

HHS published the final rule on the Confidentiality of Substance Use Disorder (SUD) Patient Records at 89 FR 12472 on February 16, 2024. It took effect on April 16, 2024, and persons subject to it had to comply with the applicable requirements by February 16, 2026 [2]. The rule lets a patient give a single consent for all future uses and disclosures for treatment, payment and health care operations, and lets covered entities and business associates that receive records under that consent redisclose them as the HIPAA rules allow, except in proceedings against the patient [1].

One provision is not yet in force: HHS tolled the effective and compliance dates of the accounting of disclosures section, 2.25, until it revises the HIPAA accounting provision at 45 CFR 164.528 [2]. That section is left out of the steps below.

## Using the steps

The first eight steps concern the Part 2 program that obtains consent and discloses; the rest concern what recipients may and may not do. Each cites the section of 42 CFR part 2 it rests on, as current on eCFR to November 12, 2026 [1]. Where a step is our suggestion, it says so. The owner under each step is a typical role, not one the rule names, unless the step says the rule names it. This page explains the rule; it is not legal advice, and state law may add its own limits.

Moraph’s teams help organizations with work like this. [See our solutions](https://www.moraph.com/solutions).

## The checklist

1. **Decide which roles the organization holds: Part 2 program, covered entity or business associate that receives Part 2 records, intermediary, or other lawful holder.** (Privacy officer with legal) Section 2.11 defines a Part 2 program as a federally assisted program, an intermediary as a person other than a Part 2 program, covered entity or business associate that receives records under a general designation for its member participants, and a lawful holder as anyone bound by Part 2 because it received records under a consent with the required notice or under an exception [1]. Section 2.12 sets which records are covered [1]. The duties in the steps below differ by role.
2. **Check that the consent form, paper or electronic, has every element the rule lists.** (Privacy officer) Section 2.31(a)(1) to (9) requires the patient’s name; who may make the use or disclosure; a specific and meaningful description of the information; the recipients; each purpose; the right to revoke in writing and how; an expiration date or event; the signature, including a person authorized under sections 2.14 or 2.15 where required; and the date signed. Electronic signatures are allowed where other law does not prohibit them [1].
3. **Offer a single consent for all future treatment, payment and health care operations, using the wording the rule accepts.** (Privacy officer with patient access staff) Section 2.31(a)(4)(i) allows recipients to be described as “my treating providers, health plans, third-party payers, and people helping to operate this program” or similar; section 2.31(a)(5)(ii) accepts “for treatment, payment, and health care operations” as the purpose; and section 2.31(a)(7) accepts “end of the treatment,” “none” or similar as the expiration [1].
4. **Add the statements a treatment, payment and operations consent must carry.** (Privacy officer) Section 2.31(a)(10) requires statements on the potential for redisclosure by the recipient, after which the records are no longer protected by Part 2, and on the consequences of refusing to sign. Section 2.31(a)(4)(iii) requires a statement that a covered entity or business associate recipient may redisclose under HIPAA, except for proceedings against the patient. Section 2.31(a)(5)(iii) requires a statement of the right to opt out of fundraising if the program will fundraise [1].
5. **Keep separate consent forms for SUD counseling notes and for use in legal proceedings.** (Privacy officer with clinical leadership) Section 2.31(b) requires consent for most uses and disclosures of SUD counseling notes, allows that consent to be combined only with another counseling notes consent, and bars conditioning treatment, payment, enrollment or eligibility on it. Section 2.31(d) bars combining consent for use in civil, criminal, administrative or legislative proceedings with any other consent [1].
6. **For disclosures through an intermediary such as a health information exchange, name the intermediary and either its members or a general designation limited to treating providers, and be ready to list disclosures on request.** (Health information exchange or interoperability lead) Section 2.31(a)(4)(ii) sets the consent wording for intermediaries. Under section 2.24, when a patient consented through a general designation, the intermediary must answer the patient’s written request, limited to the past 3 years, within 30 days, giving for each disclosure the recipient, the date and a brief description of the information [1].
7. **Before each disclosure, check that the consent has not expired, been revoked or been found false, and is not deficient on its face.** (Health information management or release of information staff) Section 2.31(c) bars disclosure on a consent that has expired, substantially fails to conform to section 2.31(a) on its face, is known to have been revoked, or is known, or through reasonable diligence could be known, to be materially false [1]. Under section 2.33(a)(2), a single treatment, payment and operations consent lasts until the patient revokes it in writing [1].
8. **Send the required notice and a copy or clear explanation of the consent with every disclosure made with consent.** (Health information management) Section 2.32(a) requires one of two statements: the longer Statement 1 or Statement 2, “42 CFR part 2 prohibits unauthorized use or disclosure of these records.” Section 2.32(b) requires a copy of the consent or a clear explanation of its scope [1]. Building both into electronic exchange as well as paper releases is our suggestion.
9. **As a covered entity or business associate receiving records under a treatment, payment and operations consent, apply the HIPAA rules to redisclosure, except in proceedings against the patient.** (Privacy officer of the receiving organization) Section 2.33(b)(1) allows such recipients to redisclose under the HIPAA regulations, except for uses and disclosures in civil, criminal, administrative and legislative proceedings against the patient. Section 2.12(d)(2)(i)(C) says a Part 2 program, covered entity or business associate receiving records under that consent is not required to segregate or segment them [1].
10. **Block use of the records against the patient in investigations and proceedings unless there is the patient’s consent or a court order under subpart E.** (Legal with release of information staff) Section 2.12(d)(1) applies this restriction to anyone who obtains the records from a Part 2 program, covered entity, business associate, intermediary or other lawful holder, whatever their status. It bars use as evidence, in agency decisions, for law enforcement investigations and in warrant applications [1]. Flagging received Part 2 records in the record system so that legal requests are routed for review is our suggestion.
11. **As a lawful holder that is not a covered entity or business associate, put contracts in place before sharing records with contractors or legal representatives for payment or operations.** (Legal and procurement) Sections 2.33(b)(3) and 2.33(c) allow such redisclosure only as necessary for the payment or operations named in the consent, under a written contract binding the recipient to Part 2. The lawful holder must give the section 2.32 notice, require safeguards and reporting of unauthorized uses, disclosures or breaches, and share only what the contractor needs [1].
12. **Accept patients’ requests to restrict treatment, payment and operations disclosures, and grant the self-pay restriction to a health plan.** (Patient access and privacy officer) Section 2.26(a) requires a Part 2 program to let patients request restrictions even after signing consent. It need not agree to most requests, but must agree to restrict disclosure to a health plan for payment or operations, not otherwise required by law, when the record concerns only an item or service paid in full by the patient or someone other than the plan [1].
13. **Keep a process to receive complaints about Part 2 compliance.** (Privacy officer) Section 2.4(a) requires a Part 2 program to provide a process to receive complaints, and section 2.4(b) allows any person to complain to the Secretary about a Part 2 program, covered entity, business associate, qualified service organization or lawful holder [1].

## Sources

1. Electronic Code of Federal Regulations. 42 CFR part 2, Confidentiality of Substance Use Disorder Patient Records (current text, checked November 14, 2026). <https://www.ecfr.gov/current/title-42/chapter-I/subchapter-A/part-2> Checked November 14, 2026.
2. Department of Health and Human Services, Federal Register (via GovInfo). Confidentiality of Substance Use Disorder (SUD) Patient Records (final rule, 89 FR 12472, February 16, 2024). <https://www.govinfo.gov/content/pkg/FR-2024-02-16/html/2024-02544.htm> Checked November 14, 2026.

Published: November 14, 2026
Canonical URL: <https://insights.moraph.com/checklist-42-cfr-part-2-consent-and-redisclosure-2024-rule>
Publisher: Moraph Insights
